speb/financial-data huggingface dataset:
CMPG.L balance_sheet (quarterly, 2024-11-30) — Ordinary Shares Number: 86876679.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Receivables: 510000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Share Issued: 90946679.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Stockholders Equity: 150710000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Tangible Book Value: 150710000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Total Assets: 158171000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Total Capitalization: 157710000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Total Debt: 7000000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Total Equity Gross Minority Interest: 150710000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Total Liabilities Net Minority Interest: 7461000.00
CMPG.L balance_sheet (quarterly, 2024-11-30) — Treasury Shares Number: 4070000.00
CMPG.L income_statement (annual, 2025-05-31) — +Operating Expense: 744000.00
CMPG.L income_statement (annual, 2025-05-31) — +Total Revenue: 5327000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Additional Paid In Capital: 10630000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 10630000.00
CMPG.L income_statement (annual, 2025-05-31) — Basic Average Shares: 87515844.00
CMPG.L income_statement (annual, 2025-05-31) — Basic EPS: 0.05
CMPG.L cash_flow (annual, 2025-05-31) — Beginning Cash Position: 1676000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Capital Stock: 4268000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Capital Stock: 4268000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Cash And Cash Equivalents: 4924000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 4924000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 4924000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 4924000.00
CMPG.L cash_flow (annual, 2025-05-31) — Cash Dividends Paid: -3947000.00
CMPG.L cash_flow (annual, 2025-05-31) — Change In Other Current Liabilities: 0.00
CMPG.L cash_flow (annual, 2025-05-31) — Change In Payable: -44000.00
CMPG.L cash_flow (annual, 2025-05-31) — Change In Prepaid Assets: 24000.00
CMPG.L cash_flow (annual, 2025-05-31) — Change In Working Capital: -20000.00
CMPG.L cash_flow (annual, 2025-05-31) — Changes In Cash: 3248000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Common Stock: 4268000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Common Stock: 4268000.00
CMPG.L cash_flow (annual, 2025-05-31) — Common Stock Dividend Paid: -3947000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Common Stock Equity: 152380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 152380000.00
CMPG.L cash_flow (annual, 2025-05-31) — Common Stock Issuance: 2522000.00
CMPG.L cash_flow (annual, 2025-05-31) — Common Stock Payments: -3277000.00
CMPG.L income_statement (annual, 2025-05-31) — Diluted Average Shares: 87515844.00
CMPG.L income_statement (annual, 2025-05-31) — Diluted EPS: 0.05
CMPG.L income_statement (annual, 2025-05-31) — Diluted NI Availto Com Stockholders: 4583000.00
CMPG.L cash_flow (annual, 2025-05-31) — Dividend Received Cfo: 4975000.00
CMPG.L cash_flow (annual, 2025-05-31) — End Cash Position: 4924000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 154532000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 154532000.00
CMPG.L cash_flow (annual, 2025-05-31) — Financing Cash Flow: -4702000.00
CMPG.L cash_flow (annual, 2025-05-31) — Free Cash Flow: 3025000.00
CMPG.L cash_flow (annual, 2025-05-31) — Gain Loss On Investment Securities: -6505000.00
CMPG.L income_statement (annual, 2025-05-31) — Gain On Sale Of Security: 4909000.00
CMPG.L income_statement (annual, 2025-05-31) — General And Administrative Expense: 586000.00
CMPG.L income_statement (annual, 2025-05-31) — Interest Expense: 322000.00
CMPG.L income_statement (annual, 2025-05-31) — Interest Income: 170000.00
CMPG.L cash_flow (annual, 2025-05-31) — Interest Paid Cfo: -334000.00
CMPG.L cash_flow (annual, 2025-05-31) — Interest Received Cfo: 170000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Invested Capital: 159380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Invested Capital: 159380000.00
CMPG.L cash_flow (annual, 2025-05-31) — Investing Cash Flow: 4925000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Investmentin Financial Assets: 154532000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 154532000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Investments And Advances: 154532000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 154532000.00
CMPG.L cash_flow (annual, 2025-05-31) — Issuance Of Capital Stock: 2522000.00
CMPG.L cash_flow (annual, 2025-05-31) — Issuance Of Debt: 5000000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPG.L cash_flow (annual, 2025-05-31) — Long Term Debt Issuance: 5000000.00
CMPG.L cash_flow (annual, 2025-05-31) — Long Term Debt Payments: -5000000.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Common Stock Issuance: -755000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Net Debt: 2076000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Net Debt: 2076000.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Foreign Currency Exchange Gain Loss: 4000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income Common Stockholders: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income Continuous Operations: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 4583000.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Income From Continuing Operations: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Income Including Noncontrolling Interests: 4583000.00
CMPG.L income_statement (annual, 2025-05-31) — Net Interest Income: -152000.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Investment Purchase And Sale: 4925000.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Issuance Payments Of Debt: 0.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Long Term Debt Issuance: 0.00
CMPG.L cash_flow (annual, 2025-05-31) — Net Other Financing Charges: 0.00
CMPG.L balance_sheet (annual, 2025-05-31) — Net Tangible Assets: 152380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 152380000.00
CMPG.L income_statement (annual, 2025-05-31) — Normalized Income: 4583000.00
CMPG.L cash_flow (annual, 2025-05-31) — Operating Cash Flow: 3025000.00
CMPG.L income_statement (annual, 2025-05-31) — Operating Revenue: 5327000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Ordinary Shares Number: 88171679.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 88171679.00
CMPG.L cash_flow (annual, 2025-05-31) — Other Non Cash Items: 152000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Other Payable: 6000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Other Payable: 6000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Payables: 6000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Payables: 6000.00
CMPG.L income_statement (annual, 2025-05-31) — Pretax Income: 4583000.00
CMPG.L cash_flow (annual, 2025-05-31) — Purchase Of Investment: -12297000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Receivables: 432000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Receivables: 432000.00
CMPG.L cash_flow (annual, 2025-05-31) — Repayment Of Debt: -5000000.00
CMPG.L cash_flow (annual, 2025-05-31) — Repurchase Of Capital Stock: -3277000.00
CMPG.L cash_flow (annual, 2025-05-31) — Sale Of Investment: 17222000.00
CMPG.L income_statement (annual, 2025-05-31) — Selling And Marketing Expense: 158000.00
CMPG.L income_statement (annual, 2025-05-31) — Selling General And Administration: 744000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Share Issued: 92531679.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Share Issued: 92531679.00
CMPG.L balance_sheet (annual, 2025-05-31) — Stockholders Equity: 152380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 152380000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Tangible Book Value: 152380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 152380000.00
CMPG.L income_statement (annual, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
CMPG.L income_statement (annual, 2025-05-31) — Tax Provision: 0.00
CMPG.L income_statement (annual, 2025-05-31) — Tax Rate For Calcs: 0.00
CMPG.L cash_flow (annual, 2025-05-31) — Taxes Refund Paid: 0.00
CMPG.L balance_sheet (annual, 2025-05-31) — Total Assets: 159888000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Total Assets: 159888000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Total Capitalization: 159380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 159380000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Total Debt: 7000000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Total Debt: 7000000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Total Equity Gross Minority Interest: 152380000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 152380000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Total Liabilities Net Minority Interest: 7508000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 7508000.00
CMPG.L balance_sheet (annual, 2025-05-31) — Treasury Shares Number: 4360000.00
CMPG.L balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 4360000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 13715000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Capital Stock: 4380000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 5938000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Federal Funds Sold: 5938000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Common Stock: 4380000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 167891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 170488000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Invested Capital: 174891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 170488000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 170488000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Net Debt: 1062000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 167891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 89450904.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Other Payable: 3434000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Payables: 3434000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Receivables: 2323000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Share Issued: 94938904.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 167891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 167891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Total Assets: 178749000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 174891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Total Debt: 7000000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 167891000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 10858000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Treasury Shares Number: 5488000.00
CMPG.L balance_sheet (quarterly, 2025-11-30) — Treasury Stock: 0.00
CMPI.L income_statement (annual, 2022-05-31) — +Operating Expense: 723000.00
CMPI.L income_statement (annual, 2022-05-31) — +Total Revenue: -12635000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Additional Paid In Capital: 622000.00
CMPI.L income_statement (annual, 2022-05-31) — Basic Average Shares: 85980755.00
CMPI.L income_statement (annual, 2022-05-31) — Basic EPS: -0.02
CMPI.L cash_flow (annual, 2022-05-31) — Beginning Cash Position: 5809000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Capital Stock: 8288000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Cash And Cash Equivalents: 7478000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Cash Cash Equivalents And Federal Funds Sold: 7478000.00
CMPI.L cash_flow (annual, 2022-05-31) — Cash Dividends Paid: -3155000.00
CMPI.L cash_flow (annual, 2022-05-31) — Change In Other Current Liabilities: 0.00
CMPI.L cash_flow (annual, 2022-05-31) — Change In Payable: -782000.00
CMPI.L cash_flow (annual, 2022-05-31) — Change In Prepaid Assets: -15000.00
CMPI.L cash_flow (annual, 2022-05-31) — Change In Working Capital: -797000.00
CMPI.L cash_flow (annual, 2022-05-31) — Changes In Cash: 1669000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Common Stock: 8288000.00
CMPI.L cash_flow (annual, 2022-05-31) — Common Stock Dividend Paid: -3155000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Common Stock Equity: 159671000.00
CMPI.L cash_flow (annual, 2022-05-31) — Common Stock Issuance: 5206000.00
CMPI.L cash_flow (annual, 2022-05-31) — Common Stock Payments: 0.00
CMPI.L income_statement (annual, 2022-05-31) — Diluted Average Shares: 85980755.00
CMPI.L income_statement (annual, 2022-05-31) — Diluted EPS: -0.02
CMPI.L income_statement (annual, 2022-05-31) — Diluted NI Availto Com Stockholders: -13372000.00
CMPI.L cash_flow (annual, 2022-05-31) — Dividend Received Cfo: 4300000.00
CMPI.L cash_flow (annual, 2022-05-31) — End Cash Position: 7478000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 159132000.00
CMPI.L cash_flow (annual, 2022-05-31) — Financing Cash Flow: 2051000.00
CMPI.L cash_flow (annual, 2022-05-31) — Free Cash Flow: 1432000.00
CMPI.L cash_flow (annual, 2022-05-31) — Gain Loss On Investment Securities: 11348000.00
CMPI.L income_statement (annual, 2022-05-31) — Gain On Sale Of Security: 8418000.00
CMPI.L income_statement (annual, 2022-05-31) — General And Administrative Expense: 642000.00
CMPI.L income_statement (annual, 2022-05-31) — Interest Expense: 153000.00
CMPI.L income_statement (annual, 2022-05-31) — Interest Income: 10000.00
CMPI.L cash_flow (annual, 2022-05-31) — Interest Paid Cfo: -181000.00
CMPI.L cash_flow (annual, 2022-05-31) — Interest Received Cfo: 10000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Invested Capital: 166671000.00
CMPI.L cash_flow (annual, 2022-05-31) — Investing Cash Flow: -1814000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Investmentin Financial Assets: 159132000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Investments And Advances: 159132000.00
CMPI.L cash_flow (annual, 2022-05-31) — Issuance Of Capital Stock: 5206000.00
CMPI.L cash_flow (annual, 2022-05-31) — Issuance Of Debt: 0.00
CMPI.L balance_sheet (annual, 2022-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L cash_flow (annual, 2022-05-31) — Long Term Debt Issuance: 0.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Common Stock Issuance: 5206000.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Foreign Currency Exchange Gain Loss: 2000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income: -13372000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income Common Stockholders: -13372000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income Continuous Operations: -13372000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income From Continuing And Discontinued Operation: -13372000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income From Continuing Operation Net Minority Interest: -13372000.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Income From Continuing Operations: -13358000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Income Including Noncontrolling Interests: -13372000.00
CMPI.L income_statement (annual, 2022-05-31) — Net Interest Income: -143000.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Investment Purchase And Sale: -1814000.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Issuance Payments Of Debt: 0.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Long Term Debt Issuance: 0.00
CMPI.L cash_flow (annual, 2022-05-31) — Net Other Financing Charges: 0.00
CMPI.L balance_sheet (annual, 2022-05-31) — Net Tangible Assets: 159671000.00
CMPI.L income_statement (annual, 2022-05-31) — Normalized Income: -13372000.00
CMPI.L cash_flow (annual, 2022-05-31) — Operating Cash Flow: 1432000.00
CMPI.L income_statement (annual, 2022-05-31) — Operating Revenue: -12635000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Ordinary Shares Number: 87257313.00
CMPI.L cash_flow (annual, 2022-05-31) — Other Non Cash Items: 142000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Other Payable: 197000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Payables: 197000.00
CMPI.L income_statement (annual, 2022-05-31) — Pretax Income: -13358000.00
CMPI.L cash_flow (annual, 2022-05-31) — Purchase Of Investment: -21019000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Receivables: 792000.00
CMPI.L cash_flow (annual, 2022-05-31) — Repurchase Of Capital Stock: 0.00
CMPI.L cash_flow (annual, 2022-05-31) — Sale Of Investment: 19205000.00
CMPI.L income_statement (annual, 2022-05-31) — Selling And Marketing Expense: 81000.00
CMPI.L income_statement (annual, 2022-05-31) — Selling General And Administration: 723000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Share Issued: 87257313.00
CMPI.L balance_sheet (annual, 2022-05-31) — Stockholders Equity: 159671000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Tangible Book Value: 159671000.00
CMPI.L income_statement (annual, 2022-05-31) — Tax Effect Of Unusual Items: 0.00
CMPI.L income_statement (annual, 2022-05-31) — Tax Provision: 14000.00
CMPI.L income_statement (annual, 2022-05-31) — Tax Rate For Calcs: 0.19
CMPI.L cash_flow (annual, 2022-05-31) — Taxes Refund Paid: -34000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Total Assets: 167402000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Total Capitalization: 166671000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Total Debt: 7000000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Total Equity Gross Minority Interest: 159671000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Total Liabilities Net Minority Interest: 7731000.00
CMPI.L balance_sheet (annual, 2022-05-31) — Treasury Stock: 0.00
CMPI.L income_statement (annual, 2023-05-31) — +Operating Expense: 689000.00
CMPI.L income_statement (annual, 2023-05-31) — +Total Revenue: -9945000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Additional Paid In Capital: 5658000.00
CMPI.L income_statement (annual, 2023-05-31) — Basic Average Shares: 88060201.00
CMPI.L income_statement (annual, 2023-05-31) — Basic EPS: -0.10
CMPI.L cash_flow (annual, 2023-05-31) — Beginning Cash Position: 7478000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Capital Stock: 5747000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Cash And Cash Equivalents: 8612000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Cash Cash Equivalents And Federal Funds Sold: 8612000.00
CMPI.L cash_flow (annual, 2023-05-31) — Cash Dividends Paid: -3441000.00
CMPI.L cash_flow (annual, 2023-05-31) — Change In Other Current Liabilities: 0.00
CMPI.L cash_flow (annual, 2023-05-31) — Change In Payable: -55000.00
CMPI.L cash_flow (annual, 2023-05-31) — Change In Prepaid Assets: 16000.00
CMPI.L cash_flow (annual, 2023-05-31) — Change In Working Capital: -39000.00
CMPI.L cash_flow (annual, 2023-05-31) — Changes In Cash: 1134000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Common Stock: 5747000.00
CMPI.L cash_flow (annual, 2023-05-31) — Common Stock Dividend Paid: -3441000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Common Stock Equity: 146253000.00
CMPI.L cash_flow (annual, 2023-05-31) — Common Stock Issuance: 2495000.00
CMPI.L cash_flow (annual, 2023-05-31) — Common Stock Payments: -1827000.00
CMPI.L income_statement (annual, 2023-05-31) — Diluted Average Shares: 88060201.00
CMPI.L income_statement (annual, 2023-05-31) — Diluted EPS: -0.10
CMPI.L income_statement (annual, 2023-05-31) — Diluted NI Availto Com Stockholders: -10645000.00
CMPI.L cash_flow (annual, 2023-05-31) — Dividend Received Cfo: 4965000.00
CMPI.L cash_flow (annual, 2023-05-31) — End Cash Position: 8612000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 146543000.00
CMPI.L cash_flow (annual, 2023-05-31) — Financing Cash Flow: -2773000.00
CMPI.L cash_flow (annual, 2023-05-31) — Free Cash Flow: 3203000.00
CMPI.L cash_flow (annual, 2023-05-31) — Gain Loss On Investment Securities: 8918000.00
CMPI.L income_statement (annual, 2023-05-31) — Gain On Sale Of Security: -907000.00
CMPI.L income_statement (annual, 2023-05-31) — General And Administrative Expense: 591000.00
CMPI.L income_statement (annual, 2023-05-31) — Interest Expense: 238000.00
CMPI.L income_statement (annual, 2023-05-31) — Interest Income: 239000.00
CMPI.L cash_flow (annual, 2023-05-31) — Interest Paid Cfo: -220000.00
CMPI.L cash_flow (annual, 2023-05-31) — Interest Received Cfo: 239000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Invested Capital: 153253000.00
CMPI.L cash_flow (annual, 2023-05-31) — Investing Cash Flow: 704000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Investmentin Financial Assets: 146543000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Investments And Advances: 146543000.00
CMPI.L cash_flow (annual, 2023-05-31) — Issuance Of Capital Stock: 2495000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L cash_flow (annual, 2023-05-31) — Net Common Stock Issuance: 668000.00
CMPI.L cash_flow (annual, 2023-05-31) — Net Foreign Currency Exchange Gain Loss: 5000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income: -10645000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income Common Stockholders: -10645000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income Continuous Operations: -10645000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income From Continuing And Discontinued Operation: -10645000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income From Continuing Operation Net Minority Interest: -10645000.00
CMPI.L cash_flow (annual, 2023-05-31) — Net Income From Continuing Operations: -10634000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Income Including Noncontrolling Interests: -10645000.00
CMPI.L income_statement (annual, 2023-05-31) — Net Interest Income: 1000.00
CMPI.L cash_flow (annual, 2023-05-31) — Net Investment Purchase And Sale: 704000.00
CMPI.L cash_flow (annual, 2023-05-31) — Net Other Financing Charges: 0.00
CMPI.L balance_sheet (annual, 2023-05-31) — Net Tangible Assets: 146253000.00
CMPI.L income_statement (annual, 2023-05-31) — Normalized Income: -10645000.00
CMPI.L cash_flow (annual, 2023-05-31) — Operating Cash Flow: 3203000.00
CMPI.L income_statement (annual, 2023-05-31) — Operating Revenue: -9945000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Ordinary Shares Number: 88488452.00
CMPI.L cash_flow (annual, 2023-05-31) — Other Non Cash Items: -1000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Other Payable: 1689000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Payables: 1689000.00
CMPI.L income_statement (annual, 2023-05-31) — Pretax Income: -10634000.00
CMPI.L cash_flow (annual, 2023-05-31) — Purchase Of Investment: -15160000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Receivables: 266000.00
CMPI.L cash_flow (annual, 2023-05-31) — Repurchase Of Capital Stock: -1827000.00
CMPI.L cash_flow (annual, 2023-05-31) — Sale Of Investment: 15864000.00
CMPI.L income_statement (annual, 2023-05-31) — Selling And Marketing Expense: 98000.00
CMPI.L income_statement (annual, 2023-05-31) — Selling General And Administration: 689000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Share Issued: 89303452.00
CMPI.L balance_sheet (annual, 2023-05-31) — Stockholders Equity: 146253000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Tangible Book Value: 146253000.00
CMPI.L income_statement (annual, 2023-05-31) — Tax Effect Of Unusual Items: 0.00
CMPI.L income_statement (annual, 2023-05-31) — Tax Provision: 11000.00
CMPI.L income_statement (annual, 2023-05-31) — Tax Rate For Calcs: 0.19
CMPI.L cash_flow (annual, 2023-05-31) — Taxes Refund Paid: -30000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Total Assets: 155421000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Total Capitalization: 153253000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Total Debt: 7000000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Total Equity Gross Minority Interest: 146253000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Total Liabilities Net Minority Interest: 9168000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Treasury Shares Number: 815000.00
CMPI.L balance_sheet (annual, 2023-05-31) — Treasury Stock: 0.00
CMPI.L income_statement (annual, 2024-05-31) — +Operating Expense: 659000.00
CMPI.L income_statement (annual, 2024-05-31) — +Total Revenue: 15069000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Additional Paid In Capital: 7299000.00
CMPI.L income_statement (annual, 2024-05-31) — Basic Average Shares: 87886130.00
CMPI.L income_statement (annual, 2024-05-31) — Basic EPS: 0.08
CMPI.L cash_flow (annual, 2024-05-31) — Beginning Cash Position: 8612000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Capital Stock: 5487000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Cash And Cash Equivalents: 1676000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Cash Cash Equivalents And Federal Funds Sold: 1676000.00
CMPI.L cash_flow (annual, 2024-05-31) — Cash Dividends Paid: -3863000.00
CMPI.L cash_flow (annual, 2024-05-31) — Change In Other Current Liabilities: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Change In Payable: 54000.00
CMPI.L cash_flow (annual, 2024-05-31) — Change In Prepaid Assets: -31000.00
CMPI.L cash_flow (annual, 2024-05-31) — Change In Working Capital: 23000.00
CMPI.L cash_flow (annual, 2024-05-31) — Changes In Cash: -6936000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Common Stock: 5487000.00
CMPI.L cash_flow (annual, 2024-05-31) — Common Stock Dividend Paid: -3863000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Common Stock Equity: 152499000.00
CMPI.L cash_flow (annual, 2024-05-31) — Common Stock Issuance: 1381000.00
CMPI.L cash_flow (annual, 2024-05-31) — Common Stock Payments: -5682000.00
CMPI.L income_statement (annual, 2024-05-31) — Diluted Average Shares: 87886130.00
CMPI.L income_statement (annual, 2024-05-31) — Diluted EPS: 0.08
CMPI.L income_statement (annual, 2024-05-31) — Diluted NI Availto Com Stockholders: 14410000.00
CMPI.L cash_flow (annual, 2024-05-31) — Dividend Received Cfo: 4696000.00
CMPI.L cash_flow (annual, 2024-05-31) — End Cash Position: 1676000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 157855000.00
CMPI.L cash_flow (annual, 2024-05-31) — Financing Cash Flow: -8164000.00
CMPI.L cash_flow (annual, 2024-05-31) — Free Cash Flow: 3060000.00
CMPI.L cash_flow (annual, 2024-05-31) — Gain Loss On Investment Securities: -16152000.00
CMPI.L income_statement (annual, 2024-05-31) — Gain On Sale Of Security: -985000.00
CMPI.L income_statement (annual, 2024-05-31) — General And Administrative Expense: 530000.00
CMPI.L income_statement (annual, 2024-05-31) — Interest Expense: 285000.00
CMPI.L income_statement (annual, 2024-05-31) — Interest Income: 190000.00
CMPI.L cash_flow (annual, 2024-05-31) — Interest Paid Cfo: -268000.00
CMPI.L cash_flow (annual, 2024-05-31) — Interest Received Cfo: 190000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Invested Capital: 159499000.00
CMPI.L cash_flow (annual, 2024-05-31) — Investing Cash Flow: -1832000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Investmentin Financial Assets: 157855000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Investments And Advances: 157855000.00
CMPI.L cash_flow (annual, 2024-05-31) — Issuance Of Capital Stock: 1381000.00
CMPI.L cash_flow (annual, 2024-05-31) — Issuance Of Debt: 0.00
CMPI.L balance_sheet (annual, 2024-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L cash_flow (annual, 2024-05-31) — Long Term Debt Issuance: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Long Term Debt Payments: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Common Stock Issuance: -4301000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Net Debt: 5324000.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Foreign Currency Exchange Gain Loss: 6000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income Common Stockholders: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income Continuous Operations: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income From Continuing And Discontinued Operation: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income From Continuing Operation Net Minority Interest: 14410000.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Income From Continuing Operations: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Income Including Noncontrolling Interests: 14410000.00
CMPI.L income_statement (annual, 2024-05-31) — Net Interest Income: -95000.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Investment Purchase And Sale: -1832000.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Issuance Payments Of Debt: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Long Term Debt Issuance: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Net Other Financing Charges: 0.00
CMPI.L balance_sheet (annual, 2024-05-31) — Net Tangible Assets: 152499000.00
CMPI.L income_statement (annual, 2024-05-31) — Normalized Income: 14410000.00
CMPI.L cash_flow (annual, 2024-05-31) — Operating Cash Flow: 3060000.00
CMPI.L income_statement (annual, 2024-05-31) — Operating Revenue: 15069000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Ordinary Shares Number: 87295859.00
CMPI.L cash_flow (annual, 2024-05-31) — Other Non Cash Items: 95000.00
CMPI.L income_statement (annual, 2024-05-31) — Pretax Income: 14410000.00
CMPI.L cash_flow (annual, 2024-05-31) — Purchase Of Investment: -20360000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Receivables: 501000.00
CMPI.L cash_flow (annual, 2024-05-31) — Repayment Of Debt: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Repurchase Of Capital Stock: -5682000.00
CMPI.L cash_flow (annual, 2024-05-31) — Sale Of Investment: 18528000.00
CMPI.L income_statement (annual, 2024-05-31) — Selling And Marketing Expense: 129000.00
CMPI.L income_statement (annual, 2024-05-31) — Selling General And Administration: 659000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Share Issued: 90550859.00
CMPI.L balance_sheet (annual, 2024-05-31) — Stockholders Equity: 152499000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Tangible Book Value: 152499000.00
CMPI.L income_statement (annual, 2024-05-31) — Tax Effect Of Unusual Items: 0.00
CMPI.L income_statement (annual, 2024-05-31) — Tax Provision: 0.00
CMPI.L income_statement (annual, 2024-05-31) — Tax Rate For Calcs: 0.00
CMPI.L cash_flow (annual, 2024-05-31) — Taxes Refund Paid: 60000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Total Assets: 160032000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Total Capitalization: 159499000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Total Debt: 7000000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Total Equity Gross Minority Interest: 152499000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Total Liabilities Net Minority Interest: 7533000.00
CMPI.L balance_sheet (annual, 2024-05-31) — Treasury Shares Number: 3255000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Additional Paid In Capital: 7596000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Capital Stock: 5504000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Cash And Cash Equivalents: 3707000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Cash Cash Equivalents And Federal Funds Sold: 3707000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Common Stock: 5504000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Common Stock Equity: 150710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 153954000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Invested Capital: 157710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Investmentin Financial Assets: 153954000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Investments And Advances: 153954000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Net Debt: 3293000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Net Tangible Assets: 150710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Ordinary Shares Number: 86876679.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Receivables: 510000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Share Issued: 90946679.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Stockholders Equity: 150710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Tangible Book Value: 150710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Total Assets: 158171000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Total Capitalization: 157710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Total Debt: 7000000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Total Equity Gross Minority Interest: 150710000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Total Liabilities Net Minority Interest: 7461000.00
CMPI.L balance_sheet (quarterly, 2024-11-30) — Treasury Shares Number: 4070000.00
CMPI.L income_statement (annual, 2025-05-31) — +Operating Expense: 744000.00
CMPI.L income_statement (annual, 2025-05-31) — +Total Revenue: 5327000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Additional Paid In Capital: 10630000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 10630000.00
CMPI.L income_statement (annual, 2025-05-31) — Basic Average Shares: 87515844.00
CMPI.L income_statement (annual, 2025-05-31) — Basic EPS: 0.05
CMPI.L cash_flow (annual, 2025-05-31) — Beginning Cash Position: 1676000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Capital Stock: 4268000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Capital Stock: 4268000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Cash And Cash Equivalents: 4924000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 4924000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 4924000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 4924000.00
CMPI.L cash_flow (annual, 2025-05-31) — Cash Dividends Paid: -3947000.00
CMPI.L cash_flow (annual, 2025-05-31) — Change In Other Current Liabilities: 0.00
CMPI.L cash_flow (annual, 2025-05-31) — Change In Payable: -44000.00
CMPI.L cash_flow (annual, 2025-05-31) — Change In Prepaid Assets: 24000.00
CMPI.L cash_flow (annual, 2025-05-31) — Change In Working Capital: -20000.00
CMPI.L cash_flow (annual, 2025-05-31) — Changes In Cash: 3248000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Common Stock: 4268000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Common Stock: 4268000.00
CMPI.L cash_flow (annual, 2025-05-31) — Common Stock Dividend Paid: -3947000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Common Stock Equity: 152380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 152380000.00
CMPI.L cash_flow (annual, 2025-05-31) — Common Stock Issuance: 2522000.00
CMPI.L cash_flow (annual, 2025-05-31) — Common Stock Payments: -3277000.00
CMPI.L income_statement (annual, 2025-05-31) — Diluted Average Shares: 87515844.00
CMPI.L income_statement (annual, 2025-05-31) — Diluted EPS: 0.05
CMPI.L income_statement (annual, 2025-05-31) — Diluted NI Availto Com Stockholders: 4583000.00
CMPI.L cash_flow (annual, 2025-05-31) — Dividend Received Cfo: 4975000.00
CMPI.L cash_flow (annual, 2025-05-31) — End Cash Position: 4924000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 154532000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 154532000.00
CMPI.L cash_flow (annual, 2025-05-31) — Financing Cash Flow: -4702000.00
CMPI.L cash_flow (annual, 2025-05-31) — Free Cash Flow: 3025000.00
CMPI.L cash_flow (annual, 2025-05-31) — Gain Loss On Investment Securities: -6505000.00
CMPI.L income_statement (annual, 2025-05-31) — Gain On Sale Of Security: 4909000.00
CMPI.L income_statement (annual, 2025-05-31) — General And Administrative Expense: 586000.00
CMPI.L income_statement (annual, 2025-05-31) — Interest Expense: 322000.00
CMPI.L income_statement (annual, 2025-05-31) — Interest Income: 170000.00
CMPI.L cash_flow (annual, 2025-05-31) — Interest Paid Cfo: -334000.00
CMPI.L cash_flow (annual, 2025-05-31) — Interest Received Cfo: 170000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Invested Capital: 159380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Invested Capital: 159380000.00
CMPI.L cash_flow (annual, 2025-05-31) — Investing Cash Flow: 4925000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Investmentin Financial Assets: 154532000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 154532000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Investments And Advances: 154532000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 154532000.00
CMPI.L cash_flow (annual, 2025-05-31) — Issuance Of Capital Stock: 2522000.00
CMPI.L cash_flow (annual, 2025-05-31) — Issuance Of Debt: 5000000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L cash_flow (annual, 2025-05-31) — Long Term Debt Issuance: 5000000.00
CMPI.L cash_flow (annual, 2025-05-31) — Long Term Debt Payments: -5000000.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Common Stock Issuance: -755000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Net Debt: 2076000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Net Debt: 2076000.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Foreign Currency Exchange Gain Loss: 4000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income Common Stockholders: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income Continuous Operations: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 4583000.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Income From Continuing Operations: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Income Including Noncontrolling Interests: 4583000.00
CMPI.L income_statement (annual, 2025-05-31) — Net Interest Income: -152000.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Investment Purchase And Sale: 4925000.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Issuance Payments Of Debt: 0.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Long Term Debt Issuance: 0.00
CMPI.L cash_flow (annual, 2025-05-31) — Net Other Financing Charges: 0.00
CMPI.L balance_sheet (annual, 2025-05-31) — Net Tangible Assets: 152380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 152380000.00
CMPI.L income_statement (annual, 2025-05-31) — Normalized Income: 4583000.00
CMPI.L cash_flow (annual, 2025-05-31) — Operating Cash Flow: 3025000.00
CMPI.L income_statement (annual, 2025-05-31) — Operating Revenue: 5327000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Ordinary Shares Number: 88171679.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 88171679.00
CMPI.L cash_flow (annual, 2025-05-31) — Other Non Cash Items: 152000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Other Payable: 6000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Other Payable: 6000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Payables: 6000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Payables: 6000.00
CMPI.L income_statement (annual, 2025-05-31) — Pretax Income: 4583000.00
CMPI.L cash_flow (annual, 2025-05-31) — Purchase Of Investment: -12297000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Receivables: 432000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Receivables: 432000.00
CMPI.L cash_flow (annual, 2025-05-31) — Repayment Of Debt: -5000000.00
CMPI.L cash_flow (annual, 2025-05-31) — Repurchase Of Capital Stock: -3277000.00
CMPI.L cash_flow (annual, 2025-05-31) — Sale Of Investment: 17222000.00
CMPI.L income_statement (annual, 2025-05-31) — Selling And Marketing Expense: 158000.00
CMPI.L income_statement (annual, 2025-05-31) — Selling General And Administration: 744000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Share Issued: 92531679.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Share Issued: 92531679.00
CMPI.L balance_sheet (annual, 2025-05-31) — Stockholders Equity: 152380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 152380000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Tangible Book Value: 152380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 152380000.00
CMPI.L income_statement (annual, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
CMPI.L income_statement (annual, 2025-05-31) — Tax Provision: 0.00
CMPI.L income_statement (annual, 2025-05-31) — Tax Rate For Calcs: 0.00
CMPI.L cash_flow (annual, 2025-05-31) — Taxes Refund Paid: 0.00
CMPI.L balance_sheet (annual, 2025-05-31) — Total Assets: 159888000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Total Assets: 159888000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Total Capitalization: 159380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 159380000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Total Debt: 7000000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Total Debt: 7000000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Total Equity Gross Minority Interest: 152380000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 152380000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Total Liabilities Net Minority Interest: 7508000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 7508000.00
CMPI.L balance_sheet (annual, 2025-05-31) — Treasury Shares Number: 4360000.00
CMPI.L balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 4360000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 13715000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Capital Stock: 4380000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 5938000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Federal Funds Sold: 5938000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Common Stock: 4380000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 167891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 170488000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Invested Capital: 174891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 170488000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 170488000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 7000000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Net Debt: 1062000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 167891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 89450904.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Other Payable: 3434000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Payables: 3434000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Receivables: 2323000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Share Issued: 94938904.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 167891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 167891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Total Assets: 178749000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 174891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Total Debt: 7000000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 167891000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 10858000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Treasury Shares Number: 5488000.00
CMPI.L balance_sheet (quarterly, 2025-11-30) — Treasury Stock: 0.00
CMPR income_statement (annual, 2021-06-30) — Basic Average Shares: 25996572.00
CMPR income_statement (annual, 2021-06-30) — Basic EPS: -3.28
CMPR income_statement (annual, 2021-06-30) — Diluted Average Shares: 25996572.00
CMPR income_statement (annual, 2021-06-30) — Diluted EPS: -3.28
CMPR balance_sheet (annual, 2021-06-30) — Held To Maturity Securities: 50713000.00
CMPR balance_sheet (annual, 2021-06-30) — Investmentin Financial Assets: 50713000.00
CMPR balance_sheet (annual, 2021-06-30) — Investments And Advances: 50713000.00
CMPR cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -60937000.00
CMPR balance_sheet (annual, 2021-06-30) — Other Equity Interest: 28000.00
CMPR income_statement (annual, 2021-06-30) — Other Special Charges: 48343000.00
CMPR balance_sheet (annual, 2021-06-30) — Preferred Securities Outside Stock Equity: 71120000.00
CMPR balance_sheet (annual, 2021-06-30) — Preferred Stock: 0.00
CMPR balance_sheet (annual, 2021-06-30) — Prepaid Assets: 72504000.00
CMPR cash_flow (annual, 2021-06-30) — Proceeds From Stock Option Exercised: 0.00
CMPR cash_flow (annual, 2021-06-30) — Purchase Of Intangibles: -60937000.00
CMPR income_statement (annual, 2021-06-30) — Salaries And Wages: 27584000.00
CMPR cash_flow (annual, 2021-06-30) — Sale Of Business: 0.00
CMPR income_statement (annual, 2022-06-30) — +Operating Expense: 1333928000.00
CMPR income_statement (annual, 2022-06-30) — +Total Revenue: 2887555000.00
CMPR balance_sheet (annual, 2022-06-30) — Accounts Payable: 313710000.00
CMPR balance_sheet (annual, 2022-06-30) — Accounts Receivable: 63885000.00
CMPR balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -557981000.00
CMPR balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 501003000.00
CMPR balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -6140000.00
CMPR income_statement (annual, 2022-06-30) — Amortization: 54497000.00
CMPR income_statement (annual, 2022-06-30) — Amortization Of Intangibles Income Statement: 54497000.00
CMPR cash_flow (annual, 2022-06-30) — Asset Impairment Charge: 0.00
CMPR income_statement (annual, 2022-06-30) — Basic Average Shares: 26094842.00
CMPR income_statement (annual, 2022-06-30) — Basic EPS: -2.08
CMPR cash_flow (annual, 2022-06-30) — Beginning Cash Position: 183023000.00
CMPR balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 180295000.00
CMPR cash_flow (annual, 2022-06-30) — Capital Expenditure: -119337000.00
CMPR cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -65297000.00
CMPR balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 106563000.00
CMPR balance_sheet (annual, 2022-06-30) — Capital Stock: 615000.00
CMPR balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 277053000.00
CMPR balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 327005000.00
CMPR cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -106572000.00
CMPR cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -3997000.00
CMPR cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: 219536000.00
CMPR cash_flow (annual, 2022-06-30) — Change In Account Payable: 109977000.00